Date:7/1/2010

oking statements. We caution that these statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors, including, among others: the company's ability to meet its obligations under existing and anticipated contractual obligations; the company's ability to develop, market, sell and distribute desirable applications, products and services and to protect its intellectual property; the ability and willingness of third-party manufacturers to timely and cost-effectively fulfill orders from the company; the ability of the company's customers to pay and the timeliness of such payments, particularly during recessionary periods; the company's ability to obtain financing as and when needed; changes in consumer demands and preferences; the company's ability to attract and retain management and employees with appropriate skills and expertise; the impact of changes in market, legal and regulatory conditions and in the applicable business environment, including actions of competitors; and other factors. The company undertakes no obligation to release publicly any revisions to any forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

'/>"/>

SOURCE Bacterin International, Inc. Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5
Related medicine technology :

1. Bacterin International Secures Three-Year Agreement to Distribute Biologic Products to Broadlanes Network of Over 6,000 Medical Facilities
2. Bacterin International Introduces OsteoSelect(R) DBM Putty
3. Bacterin International Completes $3 Million Private Placement
4. OXIS International Assumes Control and Exploitation Rights to Key L-Ergothioneine Patent Filing Representing a Major Market Opportunity
5. Max Neeman International Expands Data Management Services with Conversion Into CDISC Standard Data Model
6. Serono Symposia International Foundation in Collaboration With ESHRE Announces Public Competition in Reproductive Medicine
7. Global Pharmaceutical R&D Productivity Declining According to Thomson Reuters, CMR International
8. Varian Medical Systems Equips International Oncologys First Comprehensive Cancer Center in India
9. Chindex International, Inc. Reports Fourth Quarter and Full Year Fiscal 2010 Financial Results
10. Veteran International Health Care Executive Appointed CEO of BeneChill(R)
11. Abstract Submissions and Registration Now Open for 2nd International Symposium on MR-Guided Focused Ultrasound